| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000018702 |
| Receipt No. | R000021644 |
| Official scientific title of the study | The randomized study about pain relief after spinal surgery with the conduction block of dorsal rami with Ropivacain |
| Date of disclosure of the study information | 2015/08/17 |
| Last modified on | 2016/11/28 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | The randomized study about pain relief after spinal surgery with the conduction block of dorsal rami with Ropivacain | |
| Title of the study (Brief title) | CBDRR study | |
| Region |
|
|
| Condition | ||
| Condition | Lumbar spinal stenosis (LSS)
Cervical spondylotic myelopathy (CSM) |
|
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | For the patients who receive spinal surgery, we will perform subcutaneous and inter-paraspinal injection of Ropivacain (the conduction block of dorsal rami), and prospectively analyze whether this therapy reduce postoperative pain, or decrease the dosage amount of additional NSAIDs or weak opioid analgesics. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Visual analog scale (VAS) for wound pain at 48 hours after surgery |
| Key secondary outcomes | VAS for the wound pain at 4, 12, 24, 36, 72 hours and 7, 14days after surgery.
VAS for the back or neck pain at 3 months after surgery. The type and dosage amount of additional pain-killers. Complication. VAS for upper or lower extremity. JOA score, JOABPEQ, JOACMEQ |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | No treatment |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | We will perform the subcutaneous and inter-paraspinal injection of Ropivacain immediately before the wound closure of spine surgery. | |
| Interventions/Control_2 | We don't perform the injection. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) The patients who will receive surgery as follows
*Microendoscopic laminotomy, or microscopic bilateral decompression via unilateral approach for lumbar spinal stenosis *Laminoplasty for cervical spondylotic myelopathy 2) The patients who were explained and understood well about this survey, in addition, give written informed consent of their own free will. |
|||
| Key exclusion criteria | These patients are excluded
1) Coexisting malignant tumors 2) Pyogenic spondylitis 3) Severe hepatic disorders 4) Severe renal disorders 5) Cardiac conduction abnormalities 6) Allergic history of the ropivacain 7) Lactating women 8) Received ropivacain within 3 months before our injection 9) Received IVH perioperatively 10) Anyone who disqualified by the doctor in charge |
|||
| Target sample size | 280 | |||
| Research contact person | |
| Name of lead principal investigator | Masatoshi Hoshino / Kazunori Hayashi |
| Organization | Osaka City Graduate school of Medicine |
| Division name | Department of Orthopedic Surgery |
| Address | 1-4-3, Asahimachi, Abeno-ku, Osaka, Japan |
| TEL | 06-6645-3851 |
| m0028898@med.osaka-cu.ac.jp | |
| Public contact | |
| Name of contact person | Kazunori Hayashi |
| Organization | Osaka City Graduate school of Medicine |
| Division name | Department of Orthopedic Surgery |
| Address | 1-4-3, Asahimachi, Abeno-ku, Osaka, Japan |
| TEL | 06-6645-3851 |
| Homepage URL | |
| m0028898@med.osaka-cu.ac.jp | |
| Sponsor | |
| Institute | Osaka City Graduate school of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大阪市立大学医学部付属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021644 |